EXPRESSION OF THE WILMS-TUMOR SUPPRESSOR GENE WT1 DURING MOUSE EMBRYOGENESIS

被引:1
|
作者
RACKLEY, RR
FLENNIKEN, AM
KURIYAN, NP
KESSLER, PM
STOLER, MH
WILLIAMS, BRG
机构
[1] CLEVELAND CLIN FDN,DEPT CANC BIOL,NN1,9500 EUCLID AVE,CLEVELAND,OH 44195
[2] CLEVELAND CLIN FDN,DEPT UROL,CLEVELAND,OH 44195
[3] CLEVELAND CLIN FDN,DEPT PATHOL,CLEVELAND,OH 44195
来源
CELL GROWTH & DIFFERENTIATION | 1993年 / 4卷 / 12期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
WT1 is a Wilms' tumor suppressor gene that maps to human chromosome 11p13 and encodes a putative transcription factor implicated in controlling normal urogenital development. Sporadic homozygous mutations in WT1 result in the development of Wilms' tumor (nephroblastoma), and heterozygous germline mutations can give rise to a phenotype which includes nephropathy and urogenital abnormalities (the Denys-Drash syndrome). Thus, inappropriate expression of WT1 results in developmental abnormalities affecting the urogenital system. To better define the temporal and spatial distribution of WT1 expression during embryogenesis, we have used in situ mRNA hybridization and immunohistochemistry to examine WT1 expression in murine embryos during the period prior to and throughout active organogenesis. Prior to embryological day 9.5 (E9.5), WT1 mRNA expression is absent in the embryo proper but is strongly expressed in the maternal uterus. During the initiation of organogenesis on E11.5, WT1 mRNA is localized within the pronephric and mesonephric tissues. By E11.5, the nephrogenic cord, urogenital ridge, and condensing metanephric tissue show intense WT1 hybridization signals, and increasingly centripetal expression of WT1 in the kidney correlates with renal differentiation from days E11.5 through E16.5. The stromal cell components in the developing gonad show expression of WT1 by E10.5, whereas in the remaining organs examined, WT1 expression is restricted to the uterus, spleen, abdominal wall musculature, and mesothelial lining of organs within the thoracic and abdominal cavities. Interestingly, there is also WT1 expression in the central nervous system which localizes to the ependymal layer of the ventral aspect of the spinal cord. Immunohistochemical analyses using a WT1 antibody show that the presence of WT1 protein coincides with mRNA expression in the developing kidney, testes, uterus, and spinal cord, consistent with a role for WT1 in controlling the expression of genes involved in mesenchymal differentiation.
引用
收藏
页码:1023 / 1031
页数:9
相关论文
共 50 条
  • [31] Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
    Silberstein, G. B.
    Van Horn, K.
    Strickland, P.
    Roberts, C. T.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (15):
  • [32] Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma
    Campbell, CE
    Kuriyan, NP
    Rackley, RR
    Caulfield, MJ
    Tubbs, R
    Finke, J
    Williams, BRG
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (02) : 182 - 188
  • [33] SOMATIC MUTATION OF THE WILMS-TUMOR (WT) SUPPRESSOR GENE, WT1, IN A WT PATIENT WITH A CONSTITUTIONAL 2-15 UNBALANCED TRANSLOCATION - EVIDENCE FOR THE INVOLVEMENT OF MULTIPLE GENES IN THE ETIOLOGY OF A WILMS-TUMOR
    HUFF, V
    SCHNEIDER, NR
    STRONG, LC
    TIMMONS, CF
    TOMLINSON, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 352 - 352
  • [34] REPRESSION OF THE RETINOIC ACID RECEPTOR-ALPHA GENE BY THE WILMS-TUMOR SUPPRESSOR GENE-PRODUCT, WT1
    GOODYER, P
    DEHBI, M
    TORBAN, E
    BRUENING, W
    PELLETIER, J
    ONCOGENE, 1995, 10 (06) : 1125 - 1129
  • [35] The Wilms tumor suppressor gene wt1 is required for development of the spleen
    Herzer, U
    Crocoll, A
    Barton, D
    Howells, N
    Englert, C
    CURRENT BIOLOGY, 1999, 9 (15) : 837 - 840
  • [36] MUTATIONAL SCREENING OF THE WILMS-TUMOR GENE, WT1, IN MALES WITH GENITAL ABNORMALITIES
    CLARKSON, PA
    DAVIES, HR
    WILLIAMS, DM
    CHAUDHARY, R
    HUGHES, IA
    PATTERSON, MN
    JOURNAL OF MEDICAL GENETICS, 1993, 30 (09) : 767 - 772
  • [37] Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1)
    Adachi, Y
    Matsubara, S
    Pedraza, C
    Ozawa, M
    Tsutsui, J
    Takamatsu, H
    Noguchi, H
    Akiyama, T
    Muramatsu, T
    ONCOGENE, 1996, 13 (10) : 2197 - 2203
  • [38] REPRESSION OF THE INSULIN-LIKE GROWTH FACTOR-II GENE BY THE WILMS-TUMOR SUPPRESSOR WT1
    DRUMMOND, IA
    MADDEN, SL
    ROHWERNUTTER, P
    BELL, GI
    SUKHATME, VP
    RAUSCHER, FJ
    SCIENCE, 1992, 257 (5070) : 674 - 678
  • [39] REPRESSION OF THE TRANSFORMING GROWTH-FACTOR-BETA-1 GENE BY THE WILMS-TUMOR SUPPRESSOR WT1 GENE-PRODUCT
    DEY, BR
    SUKHATME, VP
    ROBERTS, AB
    SPORN, MB
    RAUSCHER, FJ
    KIM, SJ
    MOLECULAR ENDOCRINOLOGY, 1994, 8 (05) : 595 - 602
  • [40] ANALYSIS OF THE 11P13 WILMS-TUMOR SUPPRESSOR GENE (WT1) IN OVARIAN-TUMORS
    BRUENING, W
    GROS, P
    SATO, T
    STANIMIR, J
    NAKAMURA, Y
    HOUSMAN, D
    PELLETIER, J
    CANCER INVESTIGATION, 1993, 11 (04) : 393 - 399